Research Grants

One of HemoShear's important strategies in funding development of new human and animal surrogate systems and databases is to utilize the Small Business Innovation Research (SBIR) funding programs of the National Institutes of Health (NIH). Each grant application has the support of industry experts and executives who write letters of support and serve as program advisors for each grant. HemoShear has been awarded a number of grants which are helping to fund exciting new commercial applications of HemoShear's human and animal surrogate systems.

Phase I SBIR Grants

• Development of an Advanced System of Vascular Inflammation: Genome-Wide Profiling of Human Vascular Response to Oxidized Lipoproteins, (Grant 1R43HL102951-01, awarded by National Heart, Lung and Blood Institute)
• Development of a Hemodynamic Co-Culture Liver System for Drug Discovery and Assessment, (Grant 1R43DK091104-01, awarded by National Institute of Diabetes and Digestive and Kidney Diseases)

Phase II SBIR Grants

• Predictive Vascular System for Early Drug Development, (Grant 2R44HL102951-02, awarded by National Heart, Lung and Blood Institute)